Evolution of the Average Target: Roche Holding AG

Evolution of the Target Price: Roche Holding AG

Changes in Analyst Recommendations: Roche Holding AG

5911c625e5f8d3ed8b8c.839StiJY5Zn_X4r8JdXHBBb6fZiVQehJ3mlcmF4dmZQ.qz4K-nBpjsrOHP6xSpqwNSOKM8vtdYocjQQz9xNz4eGqOjybVG-HyZcq6Q~ff31bec514714758bbd677ee91fe4a52
28/08 Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial MT
20/08 Cancer vaccines finally garner the spotlight Alphavalue
10/08 AlphaValue/Baader Europe Downgrades to Reduce, Lifts PT MT
07/08 Morgan Stanley Upgrades Roche to Overweight, Boosts PT MT
27/07 ROCHE HOLDINGS AG : Bernstein reaffirms its Buy rating ZD
24/07 ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral ZD
24/07 Berenberg Lifts Roche Price Target Amid Upcoming Catalysts MT
23/07 Roche Holding: Good Q2; late-stage pipeline execution key to sustained re-rating Alphavalue
23/07 ROCHE HOLDINGS AG : Bernstein gives a Buy rating ZD
23/07 Swiss stocks - Factors to watch on July 23 RE
20/07 Wall Street's Patience Runs Thin Zonebourse
20/07 Could AI chip boom make ASML Europe's first trillion-dollar firm? RE
15/07 Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns MT
14/07 Where would AI lead Pharma in the long run? Alphavalue
06/07 HSBC Downgrades Roche to Hold Rating MT
30/06 ROCHE HOLDINGS AG : Goldman Sachs sticks Neutral ZD
15/06 Swiss stocks - Factors to watch on June 15 RE
11/06 Wolfe Downgrades Zealand Pharma Following Weak Tolerability Data for Obesity Drug FW
08/06 ROCHE HOLDINGS AG : Jefferies keeps a Sell rating ZD
04/06 Roche in the Red as Jefferies Maintains Underperform Rating Zonebourse
04/06 ROCHE HOLDINGS AG : Receives a Sell rating from Jefferies ZD
27/05 ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral ZD
26/05 ROCHE HOLDINGS AG : Barclays reaffirms its Buy rating ZD
22/05 BofA Ups EPS Estimates for AstraZeneca Ahead of 'Busy' Pipeline; Buy Rating Kept MT
04/05 ROCHE HOLDINGS AG : Jefferies reiterates its Sell rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.46%
+0.15%
+7.85%
+3.73%
-3.15%
+31.21%
-10.87%
+3.62%
+4.25%
Average +5.69%
Weighted average by Cap. +6.97%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
357.00CHF
Average target price
370.31CHF
Spread / Average Target
+3.73%
High Price Target
434.50CHF
Spread / Highest target
+21.71%
Low Price Target
230.00CHF
Spread / Lowest Target
-35.57%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. ROP Stock
  4. 0QOK Stock
  5. Consensus Roche Holding AG